Modified RSV F proteins and methods of their use

Details for Australian Patent Application No. 2009333484 (hide)

Owner Novavax, Inc.

Inventors Pushko, Peter; Wu, Yingyun; Massare, Michael; Liu, Ye; Smith, Gale; Zhou, Bin

Agent Allens Arthur Robinson

Pub. Number AU-A-2009333484

PCT Pub. Number WO2010/077717

Priority 61/224,787 10.07.09 US; 61/121,126 09.12.08 US; 61/169,077 14.04.09 US

Filing date 9 December 2009

Wipo publication date 8 July 2010

International Classifications

A61K 39/155 (2006.01) Medicinal preparations containing antigens or antibodies - Paramyxoviridae, e.g. parainfluenza virus

Event Publications

21 July 2011 PCT application entered the National Phase

  PCT publication WO2010/077717 Priority application(s): WO2010/077717

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009333489-Serum markers predicting clinical response to anti-TNF antibodies in patients with ankylosing spondylitis

2009333478-Methods and systems to increase accuracy in the navigation of single frequency receivers